GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
8ZQR | Q9GZV3 | Human high-affinity choline transporter CHT1 in apo state under NaCl condition. | |
8J74 | Q9GZV3 | Human high-affinity choline transporter CHT1 in the HC-3-bound outward-facing open conformation, dimeric state | |
8J75 | Q9GZV3 | Human high-affinity choline transporter CHT1 in the HC-3-bound outward-facing open conformation, monomeric state | |
8J77 | Q9GZV3 | Human high-affinity choline transporter CHT1 in the choline-bound inward-facing occluded conformation | |
8J76 | Q9GZV3 | Human high-affinity choline transporter CHT1 in the inward-facing apo-open conformation | |
4MJ4 | P35475 | Human iduronidase apo structure P21 form | |
8ONI | P01308 | Human insulin in complex with the analytical antibody S1 Fab | |
8ONI | 8ONI | Human insulin in complex with the analytical antibody S1 Fab | |
6VEP | P01308 | Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
6VEP | 6VEP | Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
6VEP | P06213 | Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
5J3H | 5J3H | Human insulin receptor domains L1-CR in complex with peptide S519C16 and 83-7 Fv | |
5J3H | P06213 | Human insulin receptor domains L1-CR in complex with peptide S519C16 and 83-7 Fv | |
5IUE | B3KUD8 | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
5IUE | P61769 | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
5IUE | 5IUE | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
5KNM | B3KUD8 | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
5KNM | P61769 | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
5KNM | Q8NHL6 | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
5KNM | 5KNM | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
3B29 | Q16873 | Human leukotriene C4 synthase in complex with dodecyl-beta-D-selenomaltoside | |
5Q0C | O00757 | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[5-(4-methoxyphenyl)thiophen-2-yl]sulfonylurea and with fructose-2,6-diphosphate | |
3CEH | P06737 | Human liver glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE5688 | Glycogen phosphorylase (E.C.2.4.1.1) |
1L5Q | P06737 | Human liver glycogen phosphorylase a complexed with caffeine, N-Acetyl-beta-D-glucopyranosylamine, and CP-403700 | Glycogen phosphorylase, liver form (E.C.2.4.4.1) |
2ZB2 | P06737 | Human liver glycogen phosphorylase a complexed with glcose and 5-chloro-N-[4-(1,2-dihydroxyethyl)phenyl]-1H-indole-2-carboxamide | |
1L5R | P06737 | Human liver glycogen phosphorylase a complexed with riboflavin, N-Acetyl-beta-D-Glucopyranosylamine and CP-403,700 | glycogen phosphorylase, liver form (E.C.2.4.4.1) |
1L7X | P06737 | Human liver glycogen phosphorylase b complexed with caffeine, N-acetyl-beta-D-glucopyranosylamine, and CP-403,700 | Glycogen phosphorylase, liver form (E.C.2.4.1.1.) |
1L5S | P06737 | Human liver glycogen phosphorylase complexed with uric acid, N-Acetyl-beta-D-glucopyranosylamine, and CP-403,700 | Glycogen phosphorylase, liver form (E.C.2.4.4.1) |
8W2J | P17858 | Human liver phosphofructokinase-1 filament in the T-state conformation | |
8W2G | P17858 | Human liver phosphofructokinase-1 in the R-state conformation | |
8W2H | P17858 | Human liver phosphofructokinase-1 in the T-state conformation | |
1NOW | p07686 | Human lysosomal beta-hexosaminidase isoform B in complex with (2R,3R,4S,5R)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium Chloride (GalNAc-isofagomine) | |
1NP0 | P07686 | Human lysosomal beta-hexosaminidase isoform B in complex with intermediate analogue NAG-thiazoline | |
6BT5 | O00222 | Human mGlu8 Receptor complexed with L-AP4 | |
6BSZ | O00222 | Human mGlu8 Receptor complexed with glutamate | |
7UAE | Q16819 | Human meprin alpha (active state) | |
7UAF | Q16819 | Human meprin alpha inhibitory complex with compound 10d (N~3~,N~3~-bis[(2H-1,3-benzodioxol-5-yl)methyl]-N-hydroxy-beta-alaninamide) | |
4U32 | P35030 | Human mesotrypsin complexed with HAI-2 Kunitz domain 1 | |
4U32 | O43291 | Human mesotrypsin complexed with HAI-2 Kunitz domain 1 | |
6UO8 | Q9UBS5 | Human metabotropic GABA(B) receptor bound to agonist SKF97541 and positive allosteric modulator GS39783 | |
6UO8 | O75899 | Human metabotropic GABA(B) receptor bound to agonist SKF97541 and positive allosteric modulator GS39783 | |
6UO9 | Q9UBS5 | Human metabotropic GABA(B) receptor bound to agonist SKF97541 in its intermediate state 2 | |
6UO9 | O75899 | Human metabotropic GABA(B) receptor bound to agonist SKF97541 in its intermediate state 2 | |
6VJM | Q9UBS5 | Human metabotropic GABA(B) receptor in its apo state | |
6VJM | O75899 | Human metabotropic GABA(B) receptor in its apo state | |
6UOA | Q9UBS5 | Human metabotropic GABA(B) receptor in its intermediate state 1 | |
6UOA | O75899 | Human metabotropic GABA(B) receptor in its intermediate state 1 | |
5C5C | Q14831 | Human metabotropic glutamate receptor 7, extracellular ligand binding domain | |
5NST | 5NST | Human monoclonal antibody with a LAIR1 insertion | |
5L0A | O00757 | Human muscle fructose-1,6-bisphosphatase E69Q mutant in active R-state in complex with fructose-1,6-bisphosphate |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024